DD274562A5 - Verfahren zur herstellung von pharmazeutischen zubereitungen - Google Patents
Verfahren zur herstellung von pharmazeutischen zubereitungen Download PDFInfo
- Publication number
- DD274562A5 DD274562A5 DD88319876A DD31987688A DD274562A5 DD 274562 A5 DD274562 A5 DD 274562A5 DD 88319876 A DD88319876 A DD 88319876A DD 31987688 A DD31987688 A DD 31987688A DD 274562 A5 DD274562 A5 DD 274562A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- pharmaceutical preparations
- prepared
- emulsion
- contain
- hydrogel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873731255 DE3731255A1 (de) | 1987-09-17 | 1987-09-17 | Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD274562A5 true DD274562A5 (de) | 1989-12-27 |
Family
ID=6336244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD88319876A DD274562A5 (de) | 1987-09-17 | 1988-09-16 | Verfahren zur herstellung von pharmazeutischen zubereitungen |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0307857B1 (da) |
| JP (1) | JP2783552B2 (da) |
| KR (1) | KR970008112B1 (da) |
| AT (1) | ATE126063T1 (da) |
| AU (1) | AU615473B2 (da) |
| CA (1) | CA1329121C (da) |
| DD (1) | DD274562A5 (da) |
| DE (2) | DE3731255A1 (da) |
| DK (1) | DK516288A (da) |
| ES (1) | ES2077559T3 (da) |
| FI (1) | FI95770C (da) |
| GR (1) | GR3017432T3 (da) |
| HU (1) | HU203045B (da) |
| IE (1) | IE70908B1 (da) |
| IL (1) | IL87778A (da) |
| NO (1) | NO179436C (da) |
| NZ (1) | NZ226209A (da) |
| PT (1) | PT88539B (da) |
| RU (1) | RU2093145C1 (da) |
| ZA (1) | ZA886903B (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5241925A (en) * | 1988-12-27 | 1993-09-07 | Dermamed | Apparatus and techniques for administering veterinary medicaments |
| US5332577A (en) * | 1988-12-27 | 1994-07-26 | Dermamed | Transdermal administration to humans and animals |
| US5130298A (en) * | 1989-05-16 | 1992-07-14 | Ethicon, Inc. | Stabilized compositions containing epidermal growth factor |
| US5324521A (en) * | 1989-12-18 | 1994-06-28 | Dermamed | Systems for transdermal administration of medicaments |
| JPH0776527A (ja) * | 1993-06-28 | 1995-03-20 | Hayashibara Biochem Lab Inc | 半固形製剤とその製造方法 |
| ITMI20031640A1 (it) * | 2003-08-08 | 2005-02-09 | Mipharm S P A | Base per gel bioadesivi. |
| CU23432B6 (es) * | 2005-11-02 | 2009-10-16 | Ct Ingenieria Genetica Biotech | Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras |
| NZ603479A (en) | 2010-05-04 | 2014-07-25 | Viscogel Ab | Chitosan composition |
| WO2018231863A1 (en) * | 2017-06-12 | 2018-12-20 | Lakewood Amedex, Inc | Bisphosphocin gel formulations and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5413223A (en) * | 1977-07-01 | 1979-01-31 | Ricoh Co Ltd | Printer unit |
| GB2016015B (en) * | 1978-01-22 | 1982-05-06 | Hayashibara Co | Method of preparing interferon and preparations containing interferon |
| JPS5598118A (en) * | 1979-01-18 | 1980-07-25 | Hayashibara Takeshi | Preparation of type-2 interferon and drug containing the same |
| SE8204382L (sv) * | 1981-07-21 | 1983-01-22 | Hayashibara Biochem Lab | Sett att framstella malcellysfaktor och anvendning derav |
| CA1190148A (en) * | 1981-10-13 | 1985-07-09 | Samuel S. Asculai | Interferon-containing compositions |
| JPS5892622A (ja) * | 1981-11-28 | 1983-06-02 | Sunstar Inc | インタ−フエロン安定配合製剤 |
| US4659696A (en) * | 1982-04-30 | 1987-04-21 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition and its nasal or vaginal use |
| JPS5910524A (ja) * | 1982-07-08 | 1984-01-20 | Toray Ind Inc | インタ−フエロン組成物およびその製造法 |
| JPS6061535A (ja) * | 1983-08-24 | 1985-04-09 | エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト | 製薬学的組成物 |
| EP0177342A3 (en) * | 1984-10-04 | 1987-12-02 | Genentech, Inc. | Oral formulation of therapeutic proteins |
| DE3603444A1 (de) * | 1986-02-05 | 1987-08-06 | Thomae Gmbh Dr K | Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha |
| US4822605A (en) * | 1986-02-18 | 1989-04-18 | Exovir, Inc. | Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
-
1987
- 1987-09-17 DE DE19873731255 patent/DE3731255A1/de not_active Ceased
-
1988
- 1988-09-13 AT AT88114944T patent/ATE126063T1/de not_active IP Right Cessation
- 1988-09-13 DE DE3854290T patent/DE3854290D1/de not_active Expired - Lifetime
- 1988-09-13 ES ES88114944T patent/ES2077559T3/es not_active Expired - Lifetime
- 1988-09-13 EP EP88114944A patent/EP0307857B1/de not_active Expired - Lifetime
- 1988-09-15 FI FI884240A patent/FI95770C/fi not_active IP Right Cessation
- 1988-09-16 JP JP63232113A patent/JP2783552B2/ja not_active Expired - Lifetime
- 1988-09-16 PT PT88539A patent/PT88539B/pt not_active IP Right Cessation
- 1988-09-16 AU AU22316/88A patent/AU615473B2/en not_active Expired
- 1988-09-16 HU HU884894A patent/HU203045B/hu unknown
- 1988-09-16 ZA ZA886903A patent/ZA886903B/xx unknown
- 1988-09-16 NO NO884123A patent/NO179436C/no not_active IP Right Cessation
- 1988-09-16 DK DK516288A patent/DK516288A/da not_active Application Discontinuation
- 1988-09-16 CA CA000577614A patent/CA1329121C/en not_active Expired - Lifetime
- 1988-09-16 DD DD88319876A patent/DD274562A5/de not_active IP Right Cessation
- 1988-09-16 IE IE281288A patent/IE70908B1/en not_active IP Right Cessation
- 1988-09-16 KR KR1019880011951A patent/KR970008112B1/ko not_active IP Right Cessation
- 1988-09-16 NZ NZ226209A patent/NZ226209A/en unknown
- 1988-09-16 IL IL87778A patent/IL87778A/xx active Protection Beyond IP Right Term
-
1992
- 1992-04-24 RU SU925011455A patent/RU2093145C1/ru active
-
1995
- 1995-09-18 GR GR950402557T patent/GR3017432T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT88539B (pt) | 1992-11-30 |
| PT88539A (pt) | 1988-10-01 |
| EP0307857A1 (de) | 1989-03-22 |
| AU615473B2 (en) | 1991-10-03 |
| KR970008112B1 (ko) | 1997-05-21 |
| DE3731255A1 (de) | 1989-04-06 |
| JPH01102029A (ja) | 1989-04-19 |
| JP2783552B2 (ja) | 1998-08-06 |
| NO884123D0 (no) | 1988-09-16 |
| FI884240A (fi) | 1989-03-18 |
| IL87778A (en) | 1993-05-13 |
| EP0307857B1 (de) | 1995-08-09 |
| NO179436B (no) | 1996-07-01 |
| IE70908B1 (en) | 1997-01-15 |
| FI95770C (fi) | 1996-03-25 |
| NO179436C (no) | 1996-10-09 |
| KR890004719A (ko) | 1989-05-09 |
| NZ226209A (en) | 1991-06-25 |
| DK516288A (da) | 1989-03-18 |
| HUT47436A (en) | 1989-03-28 |
| NO884123L (no) | 1989-03-20 |
| FI884240A0 (fi) | 1988-09-15 |
| ES2077559T3 (es) | 1995-12-01 |
| HU203045B (en) | 1991-05-28 |
| AU2231688A (en) | 1989-03-23 |
| CA1329121C (en) | 1994-05-03 |
| ATE126063T1 (de) | 1995-08-15 |
| RU2093145C1 (ru) | 1997-10-20 |
| ZA886903B (en) | 1990-05-30 |
| DK516288D0 (da) | 1988-09-16 |
| FI95770B (fi) | 1995-12-15 |
| IL87778A0 (en) | 1989-03-31 |
| GR3017432T3 (en) | 1995-12-31 |
| IE882812L (en) | 1989-03-17 |
| DE3854290D1 (de) | 1995-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69334134T2 (de) | Wässrige Formulierung enthaltend Menschliches Wachstumshormon | |
| DE69837664T2 (de) | Wässrige suspensionspräparationen mit exzellenter redispersibilität | |
| DE60027272T2 (de) | Stabile, nichtwässrige, einphasige, biokompatible, viskose Träger und Formulierungen, die diese Träger verwenden | |
| DE2418345C2 (de) | Pharmazeutisches Mittel für äußerliche Anwendung an menschlicher Haut | |
| DE69825137T2 (de) | Liposomale Erythropoietin-Dispersion | |
| EP0231816B1 (de) | Pharmazeutische Zubereitungsformen zur Stabilisierung von Interferon alpha | |
| DE2601207A1 (de) | Verfahren zur herstellung einer fluessigen zubereitung mit gesteuertem abgabevermoegen | |
| EP0456106B1 (de) | Stabile, zur pharmazeutischen Verabreichung geeignete Emulsion, Verfahren zu deren Herstellung und Emulsion zur Anwendung als Arzneimittel | |
| DD298352A5 (de) | Tretinoin enthaltende zubereitung und verfahren zu ihrer herstellung | |
| CH640736A5 (de) | Ophthalmische praeparate und verfahren zu deren herstellung. | |
| DE1934334B2 (de) | Wasserfreies Präparat auf Basis gesättigter Fettalkohole und Glykollösungsmittel | |
| EP0256285A1 (de) | Pharmazeutische Formulierung und Verfahren zu deren Herstellung | |
| DD298053A5 (de) | Verfahren zum herstellen einer stabilen zubereitung eines pharmazeutischen peptides | |
| DD274562A5 (de) | Verfahren zur herstellung von pharmazeutischen zubereitungen | |
| DE3621828C2 (da) | ||
| DE2714065A1 (de) | Instillationszubereitung | |
| DE2557615A1 (de) | Neue niclosamid-suspensionsformulierungen | |
| DE3139519A1 (de) | "topisch verabreichbare pharmazeutische zusammensetzungen, enthaltend anti-inflammatorische steroide" | |
| WO2003007988A1 (de) | Flüssige formulierung enthaltend cetuximab und einen polyoxyethylensorbitanfettsäureester | |
| DE1210127B (de) | Verfahren zur Stabilisierung von lipophile Substanzen enthaltenden waessrigen Loesungen | |
| EP0166971A1 (de) | Insulinzubereitungen, Verfahren zu deren Herstellung und deren Verwendung | |
| DE4110779A1 (de) | Liposomale formulierungen antimykotischer, antibakterieller und/oder antiphlogistischer arzneimittel fuer die lokale und vaginale anwendung | |
| EP0952819B1 (en) | Biologically active composition | |
| EP0211204A2 (de) | Verfahren zur Herstellung einer stabilen, wässrigen Fettemulsion und deren Verwendung in parenteral zu verabreichenden Gesamtnährlösungen | |
| EP1095659B1 (de) | Celluloseether stabilisierte Öl-in-Wasser Emulsionen als Träger für homöopathische und pflanzliche Wirkstoffe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |